In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques

Journal of Virology

Volumn 84, Issue 9, 2010, Pages 4714-4724

  De Vries, Rory D ^a   Lemon, Ken ^b   Ludlow, Martin ^a   McQuaid, Stephen ^b   Yüksel, Selma ^a   Van Amerongen, Geert ^a   Rennick, Linda J ^b   Rima, Bert K ^b   Osterhaus, Albert D M E ^a   De Swart, Rik L ^a   Paul Duprex, W ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P 15095; GREEN FLUORESCENT PROTEIN;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LYMPHOID TISSUE; MACACA; MEASLES; MEASLES VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PLANT GROWTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY EPITHELIUM; SKIN EPITHELIUM; SUBMUCOSA; T LYMPHOCYTE; UPPER RESPIRATORY TRACT; VIREMIA; VIRUS ATTENUATION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD11C; B-LYMPHOCYTES; DENDRITIC CELLS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LUNG; MACACA FASCICULARIS; MEASLES VIRUS; RESPIRATORY SYSTEM; STAINING AND LABELING; T-LYMPHOCYTES; VIRAL LOAD; VIRAL TROPISM; VIREMIA;

MACACA; MEASLES VIRUS;

EID: 77950856675     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02633-09     Document Type: Article

References (47)

1. Allard, S. D., K. Pletinckx, K. Breckpot, C. Heirman, A. Bonehill, A. Michiels, C. A. Van Baalen, R. A. Gruters, A. D. M. E. Osterhaus, P. Lacor, K. Thielemans, and J. L. Aerts. 2008. Functional T-cell responses generated by dendritic cells expressing the early HIV-1 proteins Tat, Rev, and Nef. Vaccine 26:3735-3741.
2. Angel, J. B., P. Walpita, R. A. Lerch, M. S. Sidhu, M. Masurekar, R. A. DeLellis, J. T. Noble, D. R. Snydman, and S. A. Udem. 1998. Vaccine-associated measles pneumonitis in an adult with AIDS. Ann. Intern. Med. 129:104-106.
3. Auwaerter, P. G., P. A. Rota, W. R. Elkins, R. J. Adams, T. DeLozier, Y. Shi, W. J. Bellini, B. R. Murphy, and D. E. Griffin. 1999. Measles virus infection in rhesus macaques: altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. 180:950-958.
4. Buckland, R., and T. F. Wild. 1997. Is CD46 the cellular receptor for measles virus? Virus Res. 48:1-9.
5. Condack, C., J.-C. Grivel, P. Devaux, L. Margolis, and R. Cattaneo. 2007. Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J. Infect. Dis. 196:541-549.
6. De Quadros, C. A., H. Izurieta, P. Carrasco, M. Brana, and G. Tambini. 2003. Progress toward measles eradication in the region of the Americas. J. Infect. Dis. 187(Suppl. 1):S102-S110.
7. De Swart, R. L. 2009. Measles studies in the macaque model. Curr. Top. Microbiol. Immunol. 330:55-72.
8. De Swart, R. L., T. Kuiken, J. Fernandez de Castro, M. J. Papania, J. L. Valdespino, P. Minor, C. Witham, S. Yüksel, H. W. Vos, G. Van Amerongen, and A. D. M. E. Osterhaus. 2006. Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. Vaccine 24:6424-6436.
9. De Swart, R. L., M. Ludlow, L. De Witte, Y. Yanagi, G. Van Amerongen, S. McQuaid, S. Yüksel, T. B. H. Geijtenbeek, W. P. Duprex, and A. D. M. E. Osterhaus. 2007. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS. Pathog. 3:e178.
10. Devaux, P., V. von Messling, W. Songsungthong, C. Springfeld, and R. Cattaneo. 2007. Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation. Virology 360:72-83. (Pubitemid 46319232)
11. Dörig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295-305. (Pubitemid 23320293)
12. Dubus, J. C., L. Vecellio, M. De Monte, J. B. Fink, D. Grimbert, J. Montharu, C. Valat, N. Behan, and P. Diot. 2005. Aerosol deposition in neonatal ventilation. Pediatr. Res. 58:10-14.
13. El Mubarak, H. S., R. L. De Swart, A. D. M. E. Osterhaus, and M. Schutten. 2005. Development of a semi-quantitative real-time RT-PCR for the detection of measles virus. J. Clin. Virol. 32:313-317.
14. El Mubarak, H. S., S. Yüksel, G. Van Amerongen, P. G. H. Mulder, M. M. Mukhtar, A. D. M. E. Osterhaus, and R. L. De Swart. 2007. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J. Gen. Virol. 88:2028-2034.
15. Enders, J. F., S. L. Katz, M. V. Milovanovic, and A. Holloway. 1960. Studies on an attenuated measles-virus vaccine. I. Development and preparation of the vaccine: techniques for assay of effects of vaccination. N. Engl. J. Med. 263:153-159.
16. Enders, J. F., and T. C. Peebles. 1954. Propagation in tissue cultures of cytopathic agents from patients with measles. Proc. Soc. Exp. Biol. Med. 86:277-286.
17. Fontana, J. M., B. Bankamp, W. J. Bellini, and P. A. Rota. 2008. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 374:71-81.
18. Garonne, P., E.-M. Neidhardt, E. Garcia, L. Galibert, C. van Kooten, and J. Banchereau. 1995. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J. Exp. Med. 182:1265-1273.
19. Gould, E. 1974. Variants of measles virus. Med. Microbiol. Immunol. 160:211-219.
20. Griffin, D. E. 2007. Measles virus, p. 1551-1585. In D. M. Knipe and P. M. Howley (ed.), Fields virology. Lippincott Williams & Wilkins, Philadelphia, PA.
21. Hashimoto, K., N. Ono, H. Tatsuo, H. Minagawa, M. Takeda, K. Takeuchi, and Y. Yanagi. 2002. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J. Virol. 76:6743-6749. (Pubitemid 34633540)
22. Hilleman, M. R. 2001. Current overview of the pathogenesis and prophylaxis of measles with focus on practical implications. Vaccine 20:651-665.
23. Leonard, V. H. J., P. L. Sinn, G. Hodge, T. Miest, P. Devaux, N. Oezguen, W. Braun, P. B. McCray, M. B. McChesney, and R. Cattaneo. 2008. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J. Clin. Invest. 118:2448-2458.
24. Ludlow, M., L. Rennick, S. Sarlang, G. Skibinski, S. McQuaid, T. Moore, R. L. De Swart, and W. P. Duprex. 2010. Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. J. Gen. Virol. doi:10.1099/vir.0. 016428-0.
25. Moss, W. J., C. J. Clements, and N. A. Halsey. 2003. Immunization of children at risk of infection with human immunodeficiency virus. Bull. World Health Organ. 81:61-70.
26. Naniche, D., G. Varior-Krishnan, F. Cervoni, T. F. Wild, B. Rossi, C. Rabourdin-Combe, and D. Gerlier. 1993. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J. Virol. 67:6025-6032. (Pubitemid 23277513)
27. Naniche, D., A. Yeh, D. S. Eto, M. Manchester, R. M. Friedman, and M. B. A. Oldstone. 2000. Evasion of host defenses by measles virus: wild-type measles virus infection interferes with induction of alpha/beta interferon production. J. Virol. 74:7478-7484. (Pubitemid 30613093)
28. Ohno, S., N. Ono, M. Takeda, K. Takeuchi, and Y. Yanagi. 2004. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 85:2991-2999.
29. Patterson, J. B., D. Thomas, H. Lewicki, M. A. Billeter, and M. B. A. Oldstone. 2000. V and C proteins of measles virus function as virulence factors in vivo. Virology 267:80-89.
30. Peebles, T. C., K. McCarthy, J. F. Enders, and A. Holloway. 1957. Behavior of monkeys after inoculation of virus derived from patients with measles and propagated in tissue culture together with observations on spontaneous infections of these animals by an agent exhibiting similar antigenic properties. J. Immunol. 78:63-74.
31. Plemper, R. K., and R. W. Compans. 2003. Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J. Virol. 77:4181-4190.
32. Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, M. Huber, C. Dotsch, G. Christiansen, and M. A. Billeter. 1995. Rescue of measles viruses from cloned DNA. EMBO J. 14:5773-5784.
33. Sattentau, Q. 2008. Avoiding the void: cell-to-cell spread of human viruses. Nat. Rev. Microbiol. 6:815-826.
34. Schwarz, A. J. 1962. Preliminary tests of a highly attenuated measles vaccine. Am. J. Dis. Child. 103:386-389.
35. Stittelaar, K. J., T. Kuiken, R. L. De Swart, G. Van Amerongen, H. W. Vos, H. G. M. Niesters, P. van Schalkwijk, T. van der Kwast, L. S. Wyatt, B. Moss, and A. D. M. E. Osterhaus. 2001. Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques. Vaccine 19:3700-3709.
36. Tahara, M., M. Takeda, F. Seki, T. Hashiguchi, and Y. Yanagi. 2007. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J. Virol. 81:2564-2572. (Pubitemid 46447022)
37. Tahara, M., M. Takeda, Y. Shirogane, T. Hashiguchi, S. Ohno, and Y. Yanagi. 2008. Measles virus infects both polarized epithelial and immune cells using distinctive receptor-binding sites on its hemagglutinin. J. Virol. 82:4630-4637. (Pubitemid 351563699)
38. Tahara, M., M. Takeda, and Y. Yanagi. 2005. Contributions of matrix and large protein genes of the measles virus Edmonston strain to growth in cultured cells as revealed by recombinant viruses. J. Virol. 79:15218-15225. (Pubitemid 43032304)
39. Takeda, M., K. Takeuchi, N. Miyajima, F. Kobune, Y. Ami, N. Nagata, Y. Suzaki, Y. Nagai, and M. Tashiro. 2000. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74:6643-6647. (Pubitemid 30429834)
40. Tatsuo, H., N. Ono, K. Tanaka, and Y. Yanagi. 2000. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893-897. (Pubitemid 30664265)
41. Tober, C., M. Seufert, H. Schneider, M. A. Billeter, I. C. Johnston, S. Niewiesk, V. Ter Meulen, and S. Schneider-Schaulies. 1998. Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J. Virol. 72:8124-8132. (Pubitemid 28421807)
42. Valdespino-Gomez, J. L., M. De Lourdes Garcia-Garcia, J. Fernandez de Castro, A. M. Henao-Restrepo, J. Bennett, and J. Sepulveda-Amor. 2006. Measles aerosol vaccination. Curr. Top. Microbiol. Immunol. 304:165-193.
43. Valsamakis, A., H. Schneider, P. G. Auwaerter, H. Kaneshima, M. A. Billeter, and D. E. Griffin. 1998. Recombinant measles viruses with mutations in the C, V, or F gene have altered growth phenotypes in vivo. J. Virol. 72:7754-7761.
44. Van Binnendijk, R. S., M. C. M. Poelen, G. Van Amerongen, P. De Vries, and A. D. M. E. Osterhaus. 1997. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J. Infect. Dis. 175:524-532.
45. Van Binnendijk, R. S., R. W. J. van der Heijden, G. Van Amerongen, F. G. C. M. UytdeHaag, and A. D. M. E. Osterhaus. 1994. Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J. Infect. Dis. 170:443-448.
46. WHO. 2009. Global reductions in measles mortality 2000-2008 and the risk of measles resurgence. Wkly. Epidemiol. Rec. 84:509-516.
47. Yanagi, Y., M. Takeda, and S. Ohno. 2006. Measles virus: cellular receptors, tropism and pathogenesis. J. Gen. Virol. 87:2767-2779.